Arvinas, Inc. (ARVN): Price and Financial Metrics


Arvinas, Inc. (ARVN)

Today's Latest Price: $48.54 USD

0.54 (1.13%)

Updated Feb 26 4:00pm

Add ARVN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ARVN Stock Summary

  • ARVN's went public 1.41 years ago, making it older than only 1.14% of listed US stocks we're tracking.
  • ARVN's price/sales ratio is 41.95; that's higher than the P/S ratio of 96.4% of US stocks.
  • Revenue growth over the past 12 months for Arvinas Inc comes in at 179.65%, a number that bests 96.5% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to ARVN, based on their financial statements, market capitalization, and price volatility, are RARE, XLRN, MEIP, FGEN, and DRNA.
  • Visit ARVN's SEC page to see the company's official filings. To visit the company's web site, go to www.arvinas.com.
ARVN Daily Price Range
ARVN 52-Week Price Range

ARVN Stock Price Chart More Charts


ARVN Price/Volume Stats

Current price $48.54 52-week high $54.95
Prev. close $48.00 52-week low $14.06
Day low $47.56 Volume 241,362
Day high $50.94 Avg. volume 294,213
50-day MA $47.52 Dividend yield N/A
200-day MA $30.25 Market Cap 1.64B

Arvinas, Inc. (ARVN) Company Bio


Arvinas Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.


ARVN Latest News Stream


Event/Time News Detail
Loading, please wait...

ARVN Latest Social Stream


Loading social stream, please wait...

View Full ARVN Social Stream

ARVN Price Returns

1-mo -4.51%
3-mo 31.19%
6-mo 86.62%
1-year 142.82%
3-year N/A
5-year N/A
YTD 18.13%
2019 219.77%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6614 seconds.